“…Recently, in the course of radioligand receptor binding studies of brain angiotensin receptors, we discovered a novel, non-AT 1 , non-AT 2 angiotensin binding site in rat brain membranes (15), which was also confirmed in mouse and human brain membranes (16,17). The non-AT 1 , non-AT 2 binding site has nanomolar affinity and high specificity for angiotensins I, II, and III and is pharmacologically, biochemically, and anatomically different from classical angiotensin type 1 (AT 1 ) and type 2 (AT 2 ) receptors, G-protein coupled Mas receptor, and neprilysin (EC 3.4.24.11, also known as neutral endopeptidase), a protease involved in the processing of angiotensins (15)(16)(17)(18)(19).…”